NASDAQ : BEAT
HeartBeam, Inc. — Financial statements
Healthcare · Health Information Services · United States
Last price 0.55 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 30.99M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 9.08M | 7.69M | 8.84M | 8.52M | 7.35M | 2.03M |
| Research & Development | 11.33M | 13.45M | 11.05M | 6.80M | 5.68M | 255.00K |
| Operating Expenses | 20.41M | 21.14M | 19.89M | 15.31M | 13.03M | 2.29M |
| Operating Income | -20.41M | -21.14M | -19.89M | -15.31M | -13.03M | -2.29M |
| Interest Expense | -2.17M | |||||
| Interest & Investment Income | 111.00K | 122.00K | 446.00K | 675.00K | 66.00K | |
| Other Non Operating Income (Expenses) | 2.00K | 2.00K | -7.00K | 3.00K | ||
| EBT Excluding Unusual Items | -20.30M | -21.02M | -19.45M | -14.64M | -12.96M | -4.45M |
| Other Unusual Items | 22.00K | |||||
| Pretax Income | -20.30M | -21.02M | -19.45M | -14.64M | -12.96M | -4.43M |
| Net Income | -20.30M | -21.02M | -19.45M | -14.64M | -12.96M | -4.43M |
| Net Income to Common | -20.30M | -21.02M | -19.45M | -14.64M | -12.96M | -4.43M |
| Shares Outstanding (Basic) | 40.98M | 33.71M | 26.65M | 20.33M | 8.17M | 4.28M |
| Shares Outstanding (Diluted) | 40.98M | 33.71M | 26.65M | 20.33M | 8.17M | 4.28M |
| EPS (Basic) | -0.50 | -0.62 | -0.73 | -0.72 | -1.59 | -1.03 |
| EPS (Diluted) | -0.50 | -0.62 | -0.73 | -0.72 | -1.59 | -1.03 |
| Free Cash Flow | -14.01M | -14.59M | -14.67M | -12.35M | -9.95M | -3.23M |
| Free Cash Flow Per Share | -0.34 | -0.43 | -0.55 | -0.61 | -1.22 | -0.75 |
| EBITDA | -20.30M | -21.10M | -19.88M | |||
| D&A For EBITDA | 106.00K | 40.00K | 7.00K | |||
| EBIT | -20.41M | -21.14M | -19.89M | -15.31M | -13.03M | -2.29M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 8.72M | 4.38M | 2.38M | 16.19M | 3.59M | 13.19M |
| Cash & Short-Term Investments | 8.72M | 4.38M | 2.38M | 16.19M | 3.59M | 13.19M |
| Inventory | 110.00K | 103.00K | ||||
| Prepaid Expenses | 164.00K | 202.00K | 393.00K | 636.00K | 445.00K | 806.00K |
| Total Current Assets | 9.00M | 4.68M | 2.77M | 16.82M | 4.04M | 14.00M |
| Property, Plant & Equipment | 1.58M | 1.10M | 450.00K | 256.00K | ||
| Other Long-Term Assets | 57.00K | 56.00K | 56.00K | 50.00K | ||
| Total Assets | 10.64M | 5.84M | 3.28M | 17.13M | 4.04M | 14.00M |
| Accounts Payable | 608.00K | 1.05M | 526.00K | 554.00K | 1.66M | 587.00K |
| Accrued Expenses | 1.85M | 2.19M | 1.10M | 640.00K | 2.00K | 1.00K |
| Total Current Liabilities | 2.46M | 3.24M | 1.62M | 1.19M | 1.67M | 588.00K |
| Total Liabilities | 2.46M | 3.24M | 1.62M | 1.19M | 1.67M | 588.00K |
| Common Stock | 6.00K | 4.00K | 3.00K | 3.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 95.20M | 79.89M | 57.92M | 52.76M | 24.56M | 22.63M |
| Retained Earnings | -87.03M | -77.29M | -56.27M | -36.83M | -22.19M | -9.22M |
| Shareholders' Equity | 8.18M | 2.60M | 1.65M | 15.94M | 2.37M | 13.41M |
| Total Liabilities & Equity | 10.64M | 5.84M | 3.28M | 17.13M | 4.04M | 14.00M |
| Net Cash (Debt) | 8.72M | 4.38M | 2.38M | 16.19M | 3.59M | 13.19M |
| Net Cash Per Share | 0.21 | 0.13 | 0.09 | 0.80 | 0.44 | 3.08 |
| Filing Date Shares Outstanding | 56.35M | 41.09M | 33.73M | 26.33M | 8.23M | 7.96M |
| Total Common Shares Outstanding | 56.35M | 40.12M | 26.96M | 26.33M | 8.01M | 7.81M |
| Working Capital | 6.54M | 1.45M | 1.15M | 15.63M | 2.37M | 13.41M |
| Book Value Per Share | 0.15 | 0.06 | 0.06 | 0.61 | 0.30 | 1.72 |
| Tangible Book Value | 8.18M | 2.60M | 1.65M | 15.94M | 2.37M | 13.41M |
| Tangible Book Value Per Share | 0.15 | 0.06 | 0.06 | 0.61 | 0.30 | 1.72 |
| Construction In Progress | 256.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -20.30M | -21.02M | -19.45M | -14.64M | -12.96M | -4.43M |
| Depreciation & Amortization | 106.00K | 40.00K | 7.00K | |||
| Stock-Based Compensation | 6.38M | 5.15M | 4.30M | 3.21M | 1.12M | 192.00K |
| Other Operating Activities | 226.00K | 226.00K | 2.14M | |||
| Change in Inventory | -110.00K | -103.00K | ||||
| Change in Accounts Payable | 528.00K | 1.53M | 428.00K | -471.00K | 1.53M | -357.00K |
| Change in Other Net Operating Assets | 144.00K | 191.00K | 243.00K | -191.00K | 361.00K | -779.00K |
| Operating Cash Flow | -13.02M | -13.99M | -14.47M | -12.09M | -9.95M | -3.23M |
| Capital Expenditures | -993.00K | -600.00K | -201.00K | -256.00K | ||
| Investing Cash Flow | 804.00K | -600.00K | -201.00K | -256.00K | ||
| Short-Term Debt Issued | 1.72M | |||||
| Total Debt Issued | 1.72M | |||||
| Short-Term Debt Repaid | -30.00K | |||||
| Total Debt Repaid | -30.00K | |||||
| Net Debt Issued (Repaid) | 1.69M | |||||
| Issuance of Common Stock | 17.68M | 16.59M | 866.00K | 24.99M | 350.00K | 14.71M |
| Financing Cash Flow | 17.68M | 16.59M | 866.00K | 24.99M | 350.00K | 16.40M |
| Net Cash Flow | 5.47M | 2.00M | -13.81M | 12.64M | -9.60M | 13.17M |
| Free Cash Flow | -14.01M | -14.59M | -14.67M | -12.35M | -9.95M | -3.23M |
| Free Cash Flow Per Share | -0.34 | -0.43 | -0.55 | -0.61 | -1.22 | -0.75 |
| Levered Free Cash Flow | -6.56M | -6.92M | -7.65M | -7.28M | -5.59M | -3.32M |
| Unlevered Free Cash Flow | -6.56M | -6.92M | -7.65M | -7.28M | -5.59M | -1.97M |
| Change in Working Capital | 562.00K | 1.61M | 671.00K | -662.00K | 1.89M | -1.14M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 23.05M | 82.66M | 62.04M | 61.87M | 39.06M | 24.05M |
| Enterprise Value | 14.32M | 80.81M | 56.27M | 42.69M | 32.51M | 28.68M |
| Last Close Price | 0.41 | 2.40 | 2.30 | 2.35 | 4.88 | 3.08 |
| PB Ratio | 2.82 | 31.76 | 37.51 | 3.88 | 16.45 | 1.79 |
| P/TBV Ratio | 2.82 | 31.76 | 37.51 | 3.88 | 16.45 | 1.79 |
| Net Debt / Equity Ratio | -1.07 | -1.68 | -1.44 | -1.02 | -1.51 | -0.98 |
| Net Debt / EBITDA Ratio | 0.43 | 0.21 | 0.12 | |||
| Net Debt / FCF Ratio | 0.62 | 0.30 | 0.16 | 1.31 | 0.36 | 4.08 |
| Quick Ratio | 3.55 | 1.35 | 1.47 | 13.56 | 2.16 | 22.43 |
| Current Ratio | 3.66 | 1.45 | 1.71 | 14.09 | 2.43 | 23.81 |
| Return on Equity (ROE) | -328.44% | -987.32% | -221.11% | -159.89% | -164.24% | -102.68% |
| Return on Assets (ROA) | -153.52% | -289.77% | -121.82% | -90.42% | -90.31% | -20.33% |
| Return on Capital Employed (ROCE) | -249.60% | -812.10% | -1,202.40% | -96.10% | -548.90% | -17.00% |
| Earnings Yield | -121.10% | -25.42% | -31.35% | -23.66% | -33.18% | -18.41% |
| FCF Yield | -60.79% | -17.65% | -23.65% | -19.96% | -25.47% | -13.43% |
| Buyback Yield / Dilution | -39.05% | -26.52% | -31.04% | -148.92% | -90.64% | -17.52% |